Leonardo wins $2.5M grant for delivery tech

Leonardo Biosystems has won a $2.5 million grant from the Texas Emerging Technology Fund, a state financing initiative that is aimed at fostering life sciences companies. Leonardo is developing new delivery technology developed by Dr. Mauro Ferrari that targets delivery of siRNA and small molecule drugs. Leonardo release

Suggested Articles

Purdue's reformulated OxyContin may stop patients from snorting or injecting the drug, but it doesn't curb abuse overall, an FDA panel determined.

Roche is gearing up to launch an eye implant to make its Lucentis AMD drug easier to use. But the drugmaker has even bigger plans for the device.

Delivery specialist IntelGenx struck two deals to develop oral films for prescription psychedelics this summer with Canada's Cybin and ATAI.